Regeneron Pharmaceuticals, Inc. (BIT:1REGN)

Regeneron Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,996	2,488	2,730	3,106	2,886	2,194
Short-Term Investments	5,474	6,524	8,115	4,636	2,809	1,393
Cash & Short-Term Investments	7,470	9,013	10,845	7,742	5,695	3,587
Cash Growth	-23.85%	-16.90%	40.07%	35.96%	58.76%	11.59%
Accounts Receivable	5,610	6,212	5,667	5,329	6,037	4,115
Total Trade Receivables	5,610	6,212	5,667	5,329	6,037	4,115
Inventory	3,206	3,087	2,581	2,402	1,951	1,917
Other Current Assets	574.3	349.2	386.6	411.2	332.4	160.8
Total Current Assets	16,860	18,661	19,479	15,884	14,015	9,779
Net Property, Plant & Equipment	4,841	4,600	4,146	3,763	3,482	3,222
Other Intangible Assets	1,352	1,149	1,039	915.5	6.7	-
Long-Term Investments	10,058	8,900	5,397	6,592	6,838	3,136
Other Long-Term Assets	5,109	4,450	3,020	2,060	1,093	1,027
Total Assets	38,219	37,759	33,080	29,215	25,435	17,163
Accounts Payable	723.9	789.5	606.6	589.2	564	475.5
Accrued Expenses	2,461	2,527	2,358	2,074	2,207	1,644
Current Portion of Leases	-	-	-	-	719.7	-
Unearned Revenue	481.9	627.7	458.9	477.9	442	577.7
Total Current Liabilities	3,667	3,944	3,423	3,141	3,933	2,697
Long-Term Debt	1,985	1,984	1,983	1,981	1,980	1,979
Long-Term Leases	720	720	720	720	-	717.2
Other Long-Term Liabilities	1,908	1,757	980.8	707.8	753.5	744.9
Total Long-Term Liabilities	4,613	4,462	3,684	3,409	2,734	3,441
Total Liabilities	8,280	8,406	7,107	6,551	6,666	6,138
Common Stock	0.1	0.1	0.1	0.1	0.1	0.1
Treasury Stock	-17,285	-15,167	-12,560	-10,353	-8,261	-6,613
Additional Paid-in Capital	13,491	12,856	11,354	9,949	8,088	6,716
Accumulated Other Comprehensive Income	52.5	-7.9	-80.9	-238.8	-26.2	29.3
Retained Earnings	33,680	31,673	27,260	23,307	18,968	10,893
Shareholders' Equity	29,939	29,354	25,973	22,664	18,769	11,025
Total Liabilities & Equity	38,219	37,759	33,080	29,215	25,435	17,163
Total Debt	2,705	2,704	2,703	2,701	2,700	2,696
Net Cash (Debt)	4,765	6,308	8,142	5,041	2,995	891.3
Net Cash Growth	-24.47%	-22.52%	61.52%	68.31%	236.03%	-64.35%
Net Cash Per Share	42.39	54.80	71.61	44.41	26.69	7.74
Book Value	29,939	29,354	25,973	22,664	18,769	11,025
Book Value Per Share	266.36	255.03	228.44	199.68	167.28	95.79
Tangible Book Value	28,587	28,205	24,935	21,749	18,762	11,025
Tangible Book Value Per Share	254.33	245.05	219.30	191.62	167.22	95.79

Updated Jun 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.